CDC approves Moderna and J&J boosters, plus mixing shots
The Centers for Disease Control and Prevention on Thursday gave final approval for certain people to receive booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines.
The agency also approved the option of mixing and matching, so people can receive a booster from a different manufacturer than their initial dose.
Those who are eligible for the Moderna booster — including people 65 and older, nursing home residents, and those 50 and up who are at severe risk if they become infected by COVID-19 — and all Johnson & Johnson vaccine recipients can sign up for boosters starting Friday. For Moderna, recipients can get a half-dose booster six months after being fully vaccinated, while those who got the single-dose Johnson & Johnson vaccine can get a booster at least two months later.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"These past 20 months have taught us many things, but mostly to have humility," CDC Director Dr. Rochelle Walensky said. "We are constantly learning about this virus, growing the evidence base and accumulating more data."
On Wednesday, the Food and Drug Administration authorized booster doses of the vaccines, followed by a CDC advisory panel earlier Thursday, leaving Walensky to make the final call on Thursday night.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Earth's mini-moon was the moon all along
Under the radar More lunar rocks are likely floating in space
By Devika Rao, The Week US Published
-
Crossword: February 4, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: February 4, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published